Clever Leaves Holdings Inc. Stock

Equities

CLVR

CA1867602031

Pharmaceuticals

Market Closed - Nasdaq 16:30:00 2024-04-26 EDT 5-day change 1st Jan Change
4.11 USD +6.14% Intraday chart for Clever Leaves Holdings Inc. +0.72% +96.23%
Sales 2022 17.8 24.33 Sales 2023 17.42 23.81 Capitalization 3.66M 5M
Net income 2022 -66M -90.22M Net income 2023 -17M -23.24M EV / Sales 2022 445,103 x
Net cash position 2022 8.59M 11.75M Net cash position 2023 4.74M 6.48M EV / Sales 2023 -62,512 x
P/E ratio 2022
-0.18 x
P/E ratio 2023
-0.18 x
Employees 296
Yield 2022 *
-
Yield 2023
-
Free-Float 87.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.14%
1 week+0.72%
Current month-15.61%
1 month-16.12%
3 months+51.66%
6 months+82.67%
Current year+96.23%
More quotes
1 week
3.59
Extreme 3.59
4.45
1 month
3.59
Extreme 3.59
5.89
Current year
2.00
Extreme 2.0022
5.89
1 year
1.72
Extreme 1.7158
8.95
3 years
1.72
Extreme 1.7158
372.00
5 years
1.72
Extreme 1.7158
583.81
10 years
1.72
Extreme 1.7158
583.81
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 18-12-31
Director of Finance/CFO 52 21-02-21
General Counsel 45 20-12-17
Members of the board TitleAgeSince
Director/Board Member 54 20-12-17
Director/Board Member 69 20-12-17
Chairman 54 22-01-31
More insiders
Date Price Change Volume
24-04-26 4.11 +6.14% 200,570
24-04-25 3.872 -1.47% 4,162
24-04-24 3.93 +1.29% 6,065
24-04-23 3.88 +1.17% 4,137
24-04-22 3.835 -6.02% 9,569

Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm

More quotes
Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.11
Average target price
-
Consensus